Texas Cardiac Arrhythmia
Texas Cardiac Arrhythmia is a private, Austin-headquartered cardiac electrophysiology practice diagnosing and treating heart rhythm disorders through ablation, device implants, and the WATCHMAN procedure across 10+ Texas and Louisiana clinic locations. It operates the Texas Cardiac Arrhythmia Institute at St. David's Medical Center and leads the EPLive international symposium.
- Company typePrivate
- Founded2009
- HeadquartersAustin, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Texas Cardiac Arrhythmia does
Texas Cardiac Arrhythmia (TCA) is a private, physician-led cardiac electrophysiology practice founded in 2009 and headquartered in Austin, Texas. The firm diagnoses and treats heart rhythm disorders — atrial fibrillation, atrial flutter, ventricular tachycardia, ventricular fibrillation, sick sinus syndrome, and related conduction abnormalities — through a comprehensive service line spanning electrophysiology studies, catheter ablation (radiofrequency, cryoablation, and pulsed field), pacemaker and implantable cardioverter defibrillator (ICD) implantation, cardiac resynchronization therapy, WATCHMAN left atrial appendage occlusion, and lead extraction. Patient-facing services are delivered via telehealth and across 10+ clinic locations spanning Austin, Dallas, Houston, Amarillo, El Paso, Corpus Christi, Bryan, San Marcos, and Round Rock in Texas plus Lake Charles, Louisiana, with international patient services extending the reach globally.
The practice's technology backbone rests on the Texas Cardiac Arrhythmia Institute at St. David's Medical Center (within the HCA Healthcare system), which combines specialized EP labs with advanced mapping platforms such as the CARTO 3 system and early-adopter access to Johnson & Johnson MedTech's QDOT MICRO Catheter for zero-fluoro ablation. TCA functions as a clinical research site for investigational devices from Abbott, Boston Scientific, Medtronic, Biosense Webster, and others, and was first in the U.S. to implant an FDA-approved novel miniaturized catheter-delivered defibrillation lead in January 2026. Education and thought leadership are anchored by the EPLive biennial international symposium, which drew a record 1,600 global participants in 2026.
TCA generates revenue on a fee-for-service professional services basis, billing through commercial insurance (Aetna, Blue Cross Blue Shield, Cigna, Humana, United Healthcare), Medicare/Medicare Advantage, Medicaid, and offering indigent and discount programs. The customer base is highly fragmented individual patients with heart rhythm disorders, supplemented by referring primary care physicians and cardiologists and an active clinical trials program. Leadership is concentrated around Executive Medical Director Dr. Andrea Natale (former Cleveland Clinic Center for Atrial Fibrillation director, FDA Task Force member), with a multi-state roster of board-certified electrophysiologists delivering care within HCA's facility infrastructure.
Texas Cardiac Arrhythmia firmographics
Firmographics- Name
- Texas Cardiac Arrhythmia
- Legal name
- Texas Cardiac Arrhythmia
- Website
- https://tcaheart.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Texas Cardiac Arrhythmia is a private, Austin-headquartered cardiac electrophysiology practice diagnosing and treating heart rhythm disorders through ablation, device implants, and the WATCHMAN procedure across 10+ Texas and Louisiana clinic locations. It operates the Texas Cardiac Arrhythmia Institute at St. David's Medical Center and leads the EPLive international symposium.
- Ownership category
- akta.pro rank
Texas Cardiac Arrhythmia industry classification
Industry- Product category
- Cardiac Electrophysiology Services
- NAICS
- Offices of Physical, Occupational and Speech Therapists, and Audiologists (621340)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)
- akta.pro primary industry
- Electrophysiology (Heart Rhythm) (HLAKABAC)
- akta.pro secondary industries
- Electrophysiology Mapping & Ablation Systems (HLAHAFAD), Cardiac Diagnostic Centers (Echo/Stress Testing/Holter) (HLAFAKAE), Cardiac Rehabilitation & Secondary Prevention (HLAKABAJ)
Keywords
Where Texas Cardiac Arrhythmia is headquartered
LocationHeadquarters
- HQ city
- Austin
- HQ country
- United States
- HQ region
- North America
Offices10 records
Markets served
Texas Cardiac Arrhythmia business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Marketing or Sales, Technology or R&D, Supply Chain
Revenue model
- Clinical Electrophysiology Services: Fee-for-service healthcare delivery model providing cardiac electrophysiology consultations, diagnostic testing, and interventional procedures to patients with heart rhythm disorders. Services include ablation procedures, pacemaker/ICD implantation, and ongoing device management.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Other | Insurance-based billing with patient responsibility determined by individual plan coverage |
Go-to-market motion3 records
Distribution channels3 records
Marketing channels7 records
Texas Cardiac Arrhythmia product offering
Product offeringCore offering
Texas Cardiac Arrhythmia is a specialized cardiac electrophysiology medical practice providing diagnostic and interventional treatment for heart rhythm disorders. Core services include cardiac ablation (radiofrequency, cryoablation, and pulsed field), pacemaker and ICD implantation, cardiac resynchronization therapy, WATCHMAN left atrial appendage closure, electrophysiology studies, and lead extraction. The practice also operates an active clinical research program and hosts the biennial EPLive international symposium for physician education.
Product overview
Texas Cardiac Arrhythmia is a medical practice specializing in cardiac electrophysiology services, offering a comprehensive range of diagnostic and treatment procedures for heart rhythm disorders. The core offering includes cardiac ablation (using radiofrequency, cryoablation, and pulse field technologies), cardiac pacing devices (pacemakers), implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT/CRTD). Supporting services include electrophysiology studies, WATCHMAN left atrial appendage closure implants, and lead extraction procedures. The practice also operates an active clinical research program conducting trials on emerging ablation technologies and cardiac devices, and hosts the biennial EPLive international symposium for medical education. Patient access is enhanced through telehealth visit capabilities. The Texas Cardiac Arrhythmia Institute at St. David's Medical Center serves as the primary research and training facility.
Differentiator
Problem solved
Functional benefit
Brands
- Texas Cardiac Arrhythmia Institute: A uniquely effective training, research and treatment facility dedicated solely to heart rhythm disorders located at St. David's Medical Center in Austin, Texas.
Quantifiable outcome
- 99 percent effective in stopping life-threatening arrhythmias with ICDs
- +2 more outcomes
Companies that use Texas Cardiac Arrhythmia
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles1 record
Texas Cardiac Arrhythmia technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Texas Cardiac Arrhythmia partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- FDA (Device Approval)coreTCA became first in the nation to implant FDA-approved novel defibrillation lead - the world's smallest catheter-delivered defibrillation lead. This demonstrates regulatory milestone achievement and early technology adoption capability.
- Boston Scientific (WATCHMAN)coreTCA was first in the state to implant the WATCHMAN Left Atrial Appendage Closure device, developed in partnership with Boston Scientific. TCA was involved in clinical trials to study its effectiveness in the United States for nearly a decade.
- St. David's Medical CentercoreThe Texas Cardiac Arrhythmia Institute at St. David's Medical Center represents a uniquely effective partnership dedicated solely to heart rhythm disorders. This training, research and treatment facility is one of its kind in the world of electrophysiology. St. David's provides state-of-the-science medical center facilities with robotics, magnetics and advanced technologies complementing TCA's physician expertise.
- Johnson & Johnson MedTechcoreTCA has adopted the QDOT MICRO Catheter system featuring micro-electrodes and accurate temperature sensors enabling zero-fluoro ablation procedures on the CARTO 3 Mapping System. This represents early adoption of advanced ablation technology.
- American Heart AssociationminorTCA participates in CycleNation events and educational programs with AHA/ASA, which has funded nearly 1,000 new research projects. TCA is a top sponsor of Austin CycleNation events.
- Multiple Medical Device CompaniescoreTCA conducts extensive clinical research studies and participates in investigational device trials with numerous companies including Abbott, Adagio Medical, Atricure, Biosense Webster, Boston Scientific, EBR Systems, Impulse Dynamics, Kardium, Laminar, LUMA Vision, Medtronic, and others. This provides patients access to new technologies before they come onto the market.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Texas Cardiac Arrhythmia competitors and assessment
Company assessmentBroad incumbents
- Cleveland Clinic — Center for Atrial Fibrillation: Cleveland Clinic's Atrial Fibrillation Center is where TCA's Executive Medical Director Dr. Natale previously served as medical director. It is a leading destination for complex AF ablation and VT cases, comparable in clinical reputation, research output, and device-maker trial participation. Strongest comparable on talent and academic stature.
- Mayo Clinic — Cardiovascular Medicine: Mayo Clinic operates one of the largest U.S. cardiac electrophysiology programs with extensive clinical research and device-maker trial partnerships. Comparable to TCA as a destination center for complex ablation, ICD/CRT implantation, and pulsed field ablation adoption. Strong national referral pipeline similar to TCA's regional Texas network.
- Massachusetts General Hospital — Cardiac Arrhythmia Service: Mass General's Cardiac Arrhythmia Service (Harvard Medical School affiliate) is one of the top U.S. EP programs and is the institution where TCA's Dr. Bode completed her Harvard EP fellowship. Comparable in clinical trial participation, complex-case expertise, and ability to attract international referrals.
- Mount Sinai — Helmsley Electrophysiology Center: Mount Sinai Heart's Helmsley Electrophysiology Center is widely regarded as a top U.S. EP program with deep clinical trial involvement and PFA leadership. Comparable to TCA as a destination for complex ablation and as a thought-leadership center publishing and speaking on emerging arrhythmia therapies.
- Johns Hopkins — Arrhythmia Service: Johns Hopkins Hospital's Arrhythmia Service offers comprehensive EP services including complex ablation, device therapy, and left atrial appendage occlusion. Comparable to TCA in academic reputation, clinical research portfolio, and ability to serve as a referral destination for complex arrhythmia cases.
- University of Pennsylvania — Electrophysiology Program: Penn Medicine's EP program is among the largest academic programs in the U.S. and trained TCA's Dr. Bode. It is comparable to TCA on complex ablation, device implantation volume, and clinical research scale, and competes for the same complex-case referral pool.
- Duke Heart Center: Duke Heart Center is a leading academic EP program with strong clinical trial participation and reputation for complex arrhythmia management. Comparable to TCA on procedural excellence, research output, and destination status for referrals from across the Southeast and nationally.
- UCLA Cardiac Arrhythmia Center: UCLA's Cardiac Arrhythmia Center is a leading West Coast EP program offering ablation, device therapy, and LAA occlusion. Comparable to TCA in clinical research and academic publishing, and competes for the same international patient segment traveling to the U.S. for complex arrhythmia care.
- NewYork-Presbyterian — Cardiac Electrophysiology: NewYork-Presbyterian's EP program (Columbia/Cornell) is among the highest-volume programs in the U.S. with deep clinical trial involvement. Comparable to TCA on procedural breadth (ablation, ICD, CRT, WATCHMAN), research activity, and ability to attract complex referrals.
- Vanderbilt Heart and Vascular Institute: Vanderbilt's EP program is a leading academic center in the Southeast with strong clinical trial and ablation programs. Comparable to TCA as a regional destination for complex arrhythmia care and as a research partner for device manufacturers.
Market position
Weaknesses5 records
Competitive moat5 records
Key risks1 record
Key highlights7 records
Customer concentration
Texas Cardiac Arrhythmia social profiles
Digital presenceTexas Cardiac Arrhythmia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Texas Cardiac Arrhythmia leadership team
Management profileNumber of profiles
Profiles2 records
Texas Cardiac Arrhythmia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Texas Cardiac Arrhythmia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Texas Cardiac Arrhythmia
What does Texas Cardiac Arrhythmia do?
Texas Cardiac Arrhythmia is a specialized cardiac electrophysiology medical practice providing diagnostic and interventional treatment for heart rhythm disorders. Core services include cardiac ablation (radiofrequency, cryoablation, and pulsed field), pacemaker and ICD implantation, cardiac resynchronization therapy, WATCHMAN left atrial appendage closure, electrophysiology studies, and lead extraction. The practice also operates an active clinical research program and hosts the biennial EPLive international symposium for physician education.
Is Texas Cardiac Arrhythmia a public or private company?
Texas Cardiac Arrhythmia is a private company. It is classified as corporate owned and is currently operating.
When was Texas Cardiac Arrhythmia founded?
Texas Cardiac Arrhythmia was founded in 2009. It employs 1 to 10 people.
Where is Texas Cardiac Arrhythmia based?
Texas Cardiac Arrhythmia is headquartered in Austin, United States, in the North America region.
How does Texas Cardiac Arrhythmia make money?
One revenue line is on record: clinical Electrophysiology Services.
Who are Texas Cardiac Arrhythmia's main competitors?
Broad incumbents on record are Cleveland Clinic — Center for Atrial Fibrillation, Mayo Clinic — Cardiovascular Medicine, Massachusetts General Hospital — Cardiac Arrhythmia Service, Mount Sinai — Helmsley Electrophysiology Center, Johns Hopkins — Arrhythmia Service, University of Pennsylvania — Electrophysiology Program, Duke Heart Center, UCLA Cardiac Arrhythmia Center, NewYork-Presbyterian — Cardiac Electrophysiology and Vanderbilt Heart and Vascular Institute.
Does Texas Cardiac Arrhythmia have an API?
No public API is recorded for Texas Cardiac Arrhythmia.
What industry is Texas Cardiac Arrhythmia in?
Texas Cardiac Arrhythmia's product category is Cardiac Electrophysiology Services. Its primary akta.pro industry code is HLAKABAC, Electrophysiology (Heart Rhythm), with a secondary code of HLAHAFAD, Electrophysiology Mapping & Ablation Systems. Its NAICS code is 621340 and its SIC code is 8011.